| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $8K | +50.8% |
| Cost of Revenue | $177K | +5.2% |
| Gross Profit | -$169K | -3.7% |
| R&D Expense | $103K | — |
| SG&A Expense | $3.3M | +209.2% |
| Operating Income | -$4.7M | -282.0% |
| Income Tax | $0 | — |
| Net Income | -$4.7M | -278.7% |
| EPS (Basic) | -$0.44 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $0 | -100.0% |
| Inventory | $544K | -67.3% |
| Current Assets | $70K | +59.1% |
| Total Assets | $686K | -61.8% |
| Current Liabilities | $194K | -14.5% |
| Total Liabilities | $394K | +42.1% |
| Stockholders' Equity | $295K | -80.0% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +51.6% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $1.2M | -45.8% |
| Free Cash Flow | -$1.2M | +51.6% |
| -266.7% |
| EPS (Diluted) | -$0.44 | -266.7% |